Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-25
DOI
10.1038/s41419-022-04700-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
- (2021) Erica C. Nakajima et al. CLINICAL CANCER RESEARCH
- m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
- (2020) Bo Tang et al. Molecular Cancer
- Phase 1b study of Wnt inhibitor ipafricept (IPA) with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer (mPDAC).
- (2020) Efrat Dotan et al. CLINICAL CANCER RESEARCH
- Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
- (2019) Rahat Jahan et al. EBioMedicine
- USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
- (2019) Pingping Hou et al. GENES & DEVELOPMENT
- RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
- (2019) Wenchao Liu et al. International Journal of Nanomedicine
- ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
- (2019) Praneeth R. Kuninty et al. Science Advances
- CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth
- (2019) Victoria M.-Y. Wang et al. NATURE CELL BIOLOGY
- TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths
- (2019) Nicole Maloney Belle et al. Nature Communications
- Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
- (2019) Han Poh et al. Cancers
- Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
- (2019) Ru-Mei Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy
- (2018) Tao Ma et al. CANCER LETTERS
- Functionally specific optogenetic modulation in primate visual cortex
- (2018) Mykyta M. Chernov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer
- (2018) Yoshiki Taniguchi et al. WORLD JOURNAL OF SURGERY
- Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling
- (2018) Zhengle Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
- (2018) Vijay Pandey et al. Cell Death & Disease
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
- (2017) Chaoyang Sun et al. Science Translational Medicine
- Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis
- (2017) Akram Yusup et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
- (2017) Qing-Yun Chong et al. Oncotarget
- Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent
- (2017) Ming-Liang You et al. Oncotarget
- Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells
- (2017) Vijay Pandey et al. Oncotarget
- Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
- (2017) Euphemia Y. Leung et al. Frontiers in Oncology
- SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression
- (2016) Feifei Cheng et al. CANCER LETTERS
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
- (2015) Karina G. Thomsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation
- (2015) Omesha Perera et al. CANCER LETTERS
- TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer
- (2015) F. E. B. May et al. ENDOCRINE-RELATED CANCER
- Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
- (2015) Xiao-Nan Wang et al. MEDICINE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2
- (2015) Wai-Hoe Lau et al. PLoS One
- Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma
- (2015) Nagarajan Kannan et al. NEOPLASIA
- The value of trefoil factor 3 expression in predicting the long-term outcome and early recurrence of colorectal cancer
- (2014) KIYOTO MORITO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer
- (2013) Aiping Ding et al. PLoS One
- TFF3 and survivin expressions associate with a lower survival rate in gastric cancer
- (2012) Jia-Rong Meng et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
- (2011) Carol Kilkenny et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Signal Transducer and Activator of Transcription (STAT)-5A and STAT5B Differentially Regulate Human Mammary Carcinoma Cell Behavior
- (2009) Jian-Zhong Tang et al. ENDOCRINOLOGY
- Trefoil Factor 3 Stimulates Human and Rodent Pancreatic Islet β-Cell Replication with Retention of Function
- (2008) Patrick T. Fueger et al. MOLECULAR ENDOCRINOLOGY
- Are trefoil factors oncogenic?
- (2007) Jo K. Perry et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started